A Study to Evaluate the Safety, Tolerability, and Efficacy of BIIB017 (Peginterferon Beta-1a) in Pediatric Participants for the Treatment of Relapsing-Remitting Multiple Sclerosis
Clinical trial NCT03958877 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03958877
- Sponsor
- Biogen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-18
- Primary completion
- 2027-05-20
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.